Clinical analysis of the usefulness of letermovir for prevention of cytomegalovirus infection after haploidentical hematopoietic stem cell transplantation

被引：0
|
作者：
马瑞
机构：
[1] Peking Univ Instit Hematol
[2] Peking Univ People’s Hosp
[3] Hematopoietic Stem Cell Transplant
[4] Beijing Key Lab
[5] Natl Clin Hematol Dis Res Center
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2023年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R457.7 [骨髓移植];
学科分类号：
摘要：
Objective To analyze the efficacy and safety of letermovir in primary prophylaxis of cytomegalovirus(CMV) reactivation in patients receiving haploidentical hematopoietic stem cell transplantation.Methods This retrospective,cohort study was conducted using data of patients who underwent haploidentical transplantation at Peking University Institute of Hematology and received letermovir for primary prophylaxis between May 1,
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation
    Li, Wen-Wen
    Zhang, Yong-Mei
    Shen, Meng-Zhu
    Mo, Xiao-Dong
    BLOOD SCIENCE, 2024, 6 (01):
  • [2] Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation
    Razonable, Raymund R.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (04) : 286 - 291
  • [3] Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation
    RICHERT-PRZYGONSKA, M. O. N. I. K. A.
    JAREMEK, K. A. M. I. L. A.
    DEBSKI, R. O. B. E. R. T.
    KONIECZEK, J. O. A. N. N. A.
    LECKA, M. O. N. I. K. A.
    DZIEDZIC, M. A. G. D. A. L. E. N. A.
    BOGIEL, T. O. M. A. S. Z.
    STYCZYNSKI, J. A. N.
    CZYZEWSKI, K. R. Z. Y. S. Z. T. O. F.
    ANTICANCER RESEARCH, 2022, 42 (07) : 3607 - 3612
  • [4] LETERMOVIR CYTOMEGALOVIRUS PROPHYLAXIS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Deresinski, Stanley C.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (03) : I - II
  • [5] Clinical Observation of Sequential Prophylaxis with Letermovir Injection and Tablets for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Pang, Aiming
    Zheng, Yawei
    Chen, Shulian
    Shen, Yuyan
    Zhao, Xiaoli
    Ni, Xiaofei
    Zhang, Lining
    Wang, Jiali
    Cao, Wenbin
    Chen, Xin
    Cao, Yigeng
    Jiang, Erlie
    BLOOD, 2024, 144 : 7292 - 7292
  • [6] Letermovir for Primary Cytomegalovirus Prevention in Haploidentical Stem Cell Transplant Recipients
    Patel, Omik S.
    Thomas, Elizabeth
    Ganguly, Siddhartha
    McGuirk, Joseph P.
    Abhyankar, Sunil
    Singh, Anurag K.
    Lin, Tara
    Shune, Leyla
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S336 - S336
  • [7] Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation
    Chen, Teaghan T.
    David, Alexandria P.
    Barthelmess, Erin K.
    MacBrayne, Christine E.
    PEDIATRIC BLOOD & CANCER, 2024, 70 (11)
  • [8] Letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplantation
    Azharuddin, Md
    Sharma, Manju
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 149 - 149
  • [9] Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients
    Foolad, Farnaz
    Aitken, Samuel L.
    Chemaly, Roy F.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (10) : 931 - 941
  • [10] Cytomegalovirus Infection in Pediatric Haploidentical Hematopoietic Stem Cell Transplantation at a Single Center
    Kang, Sung Han
    Kim, Hyery
    Seo, Jong Jin
    Im, Ho Joon
    Choi, Eun Seok
    Koh, Kyung-Nam
    Suh, Jin Kyung
    BLOOD, 2016, 128 (22)
12345